This company is not actively trading or the ticker does belong to another company in our database now.
Insider Roster
- Louis Bradley Radoff, Director, 2025-08-20
- J Steven Pully, Director, 2025-08-20
- Patricia Eckert, Chief Financial Officer, 2025-08-20
- Jonathan Couchman, Director, 2025-08-20
- Kara Cannon, Chief Executive Officer, 2025-08-20
- Mary Tagliaferri, Director, 2024-02-03
- G. James Wolf, Other, 2023-02-14
- B. Ian Walters, Director, 2023-02-14
- Hamid Erfanian, Chief Executive Officer, 2022-11-28
- David Bench, Chief Financial Officer, 2022-06-15
- Harbert Discovery Co-Investment Fund I Gp, Llc, Large Shareholder, 2021-03-17
- Harbert Discovery Co-Investment Fund I, Lp, Large Shareholder, 2021-03-17
- Harbert Discovery Fund Gp, Llc, Large Shareholder, 2021-03-17
- Kenan Lucas, Large Shareholder, 2021-03-17
- F. John Bryant, Large Shareholder, 2021-03-17
- Harbert Discovery Fund, Lp, Large Shareholder, 2021-03-17
- Harbert Fund Advisors, Inc., Large Shareholder, 2021-03-17
- Harbert Management Corp, Large Shareholder, 2021-03-17
- J Raymond Harbert, Large Shareholder, 2021-03-17
- W Barry Weiner, President and Treasurer, 2021-01-14
- J. Rebecca Fischer, Director, 2021-01-14
- Elazar Rabbani, Chief Executive Officer, 2021-01-14
- Dov Perlysky, Director, 2021-01-14
- Fabian Blank, Director, 2020-04-30
- Iv J Peter Clemens, Director, 2020-04-30
- M. Gregory Bortz, Director, 2019-01-18
- Michael James O'brien, Evp Of Finance, 2019-01-04
- A. Bruce Hanna, Director, 2019-01-04
- L Bernard Kasten, Director, 2016-03-18
- C David Goldberg, Vp Corpdev Igm Enz Clin Labs, 2016-03-16
- B Herbert Bass, Vp Of Finance, 2014-01-22
- P Andrew Whiteley, Coo, Enzo Life Sciences, Inc., 2014-01-22
- R. Andrew Crescenzo, Senior Vp Of Finance, 2014-01-22
- H B Stephen Kent, Director, 2012-01-31
- W Carl Balezentis, Pres., Enzo Life Sciences, 2010-12-20
- F Melvin Lazar, Director, 2010-03-08
- Irwin Gerson, Director, 2010-03-08
- Kevin Krenitsky, President, Enzo Clinical Labs, 2010-02-02
- K Shahram Rabbani, Officer, Director, 2009-07-06
- Christine Fischette, Officer, 2009-01-26
Show All Insiders (40) Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
| 1. | | 0 | $0 | | 0% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| Other | $1.29 | 5,000 | $6,450.00 | 115,000 | 2023-02-13 | Filing |
| Other | $1.29 | 5,000 | $6,425.00 | 4,100,000 | 2023-02-13 | Filing |
| Other | $1.29 | 5,000 | $6,450.00 | 4,095,000 | 2023-02-10 | Filing |
| Large Shareholder | $1.40 | 11,800 | $16,520.00 | 4,090,000 | 2023-01-27 | Filing |
| Large Shareholder | $2.15 | 3,500 | $7,525.00 | 418,500 | 2022-11-01 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
| Large Shareholder | $4.54 | 100,000 | $453,900.00 | 5,175,913 | 2021-03-16 | Filing |
| Large Shareholder | $4.70 | 200,000 | $940,000.00 | 5,275,913 | 2021-03-16 | Filing |
| Large Shareholder | $5.00 | 44,768 | $223,840.00 | 5,475,913 | 2021-03-15 | Filing |
| Large Shareholder | $4.75 | 100,000 | $475,000.00 | 5,520,681 | 2021-03-15 | Filing |
| Officer | $7.75 | 11,000 | $85,250.00 | 1,302,111 | 2018-01-17 | Filing |
Filing Period:
| No. | Name | Shares | Value | % Port |
| 1. | | 0 | $0 | 0% |
| 2. | | 0 | $0 | 0% |
| 3. | | 0 | $0 | 0% |
| 4. | | 0 | $0 | 0% |
| 5. | | 0 | $0 | 0% |